RevBio

RevBio is headquartered in Lowell, Massachusetts, and was founded in 2014 by Brian Hess. The company is developing TETRANITE®, a synthetic bone adhesive bioinspired by the sandcastle worm. TETRANITE is described as a patented biomaterial intended for bone repair across neurosurgical, orthopaedic, dental, and animal health indications, and RevBio is conducting its first-in-human clinical trial on the bone glue.

RevBio was founded in 2014 by Brian Hess with the goal of commercializing TETRANITE®, a regenerative bone adhesive. The company is headquartered in Lowell, Massachusetts, and is a MassChallenge start-up accelerator alum. It has won over 10 grants, received multiple patents, and is conducting its first-in-human clinical trial on its biomimetic bone glue.

Developer of a patented synthetic bone adhesive platform for bone repair.

• TETRANITE®

  A patented synthetic bone adhesive bioinspired by the sandcastle worm, intended for bone repair in neurosurgical, orthopaedic, dental, and animal health indications.

• 2021.02.04

  Reported2021.02.04

  RevBio initiates canine dental clinical study[3]RevBio启动犬类牙科临床研究prnewswire.com

  RevBio announced that it had initiated a clinical study to evaluate its bone adhesive biomaterial in dogs’ tooth-extraction sockets, with the aim of assessing healing and jaw support.

• 2020.08.04

  Reported2020.08.04

  LaunchPad Medical rebrands as RevBio[4]LaunchPad Medical更名为RevBioprnewswire.com

  LaunchPad Medical announced that it had rebranded under the name RevBio and adopted the tagline “Transforming Bone Repair.” The company said the new name was chosen to better convey its objective of developing the Tetranite bone adhesive biomaterial platform.

Read more

1. 1REVBIO TETRANITE IS A NOVEL REGENERATIVE BONE GLUErevbio.com
2. 2About RevBio - REVBIOrevbio.com
3. 3RevBio启动犬类牙科临床研究prnewswire.com
4. 4LaunchPad Medical更名为RevBioprnewswire.com